Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 12, 2014 05:30 ET | Source: Achaogen, Inc.

Achaogen Announces Pricing of Initial Public Offering

SOUTH SAN FRANCISCO, Calif., March 12, 2014 (GLOBE NEWSWIRE) -- Achaogen, Inc., a clinical-stage biopharmaceutical company developing novel antibacterials to treat multi-drug resistant (MDR)...